Legal Opinion
United States ex rel. JKJ P'ship 2011, LLP v. Sanofi Aventis, U.S., LLC (In re Plavix Mktg., Sales Practices & Prods. Liab. Litig.)
District Court, D. New Jersey
Decided May 30, 2018No. MDL No. 2418; Civil Action No. 11–6476 (FLW)PublishedCited by 3 opinions
1Opinion of the Court
*820WOLFSON, United States District Judge:
Before the Court is the motion of Defendants Sanofi-Aventis U.S., LLC; Sanofi US Services, Inc.; Aventis Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively "Defendants"), to dismiss the Second Amended Complaint of qui tam Plaintiff and relator JKJ Partnership 2011, LLP ("JKJ"), for lack of jurisdiction, pursuant to Fed. R. Civ. P. 12(b)(1), and for failure to state a claim, pursuant to Fed. R. Civ. P. 12(b)(6). Defendants contend (i) that JKJ's claims based on conduct…
2Cases cited28 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
- Fowler v. UPMC SHADYSIDECourt of Appeals for the Third Circuit · 2009
- Santiago v. Warminster TownshipCourt of Appeals for the Third Circuit · 2010
23 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- In Re: Plavix Marketing v.Court of Appeals for the Third Circuit · 2020
- UNITED STATES OF AMERICA v. SANOFI-AVENTIS U.S. INC.District Court, D. New Jersey · 2021
- United States v. Sanofi Aventis U.S. LLCSupreme Court of Delaware · 2020